TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact
Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for EIF4E
check button Gene summary
Basic gene informationGene symbolEIF4E
Gene nameeukaryotic translation initiation factor 4E
SynonymsAUTS19|CBP|EIF4E1|EIF4EL1|EIF4F
CytomapUCSC genome browser: 4q23
Type of geneprotein-coding
RefGenesNM_001130678.1,
NM_001130679.1,NM_001968.3,
DescriptioneIF-4EeIF-4F 25 kDa subuniteukaryotic translation initiation factor 4E-like 1mRNA cap-binding protein
Modification date20141207
dbXrefs MIM : 133440
HGNC : HGNC
HPRD : 00591
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_EIF4E
BioGPS: 1977
PathwayNCI Pathway Interaction Database: EIF4E
KEGG: EIF4E
REACTOME: EIF4E
Pathway Commons: EIF4E
ContextiHOP: EIF4E
ligand binding site mutation search in PubMed: EIF4E
UCL Cancer Institute: EIF4E
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesTiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)BladderBone marrowTestis
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)BLCALAMLTGCT
Reference showing the relevant tissue of EIF4E
Description by TissGene annotationsCancer gene
Have significant anti-correlated miRNA
TissgsLTS
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID
GO:0006417regulation of translation22578813
GO:0006417regulation of translation22578813


Top
TissGeneExp for EIF4E

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR


Top
TissGene-miRNA for EIF4E

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples
LUADhsa-miR-200c-3pMIMAT00006170.04-0.2760
LUADhsa-miR-409-3pMIMAT00016390.012-0.3260


Top
TissGeneMut for EIF4E
TissGeneSNV for EIF4E

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.M101IUCEC1
p.M101LSKCM1
p.R173KESCA1
p.P191ABLCA1
p.S82CLUAD1
p.N33KKIRC1
p.F48SLUAD1
p.N13KKIRC1
p.D90GHNSC1
p.P190SLUAD1
p.S24CSTAD1
p.F47LLGG1
p.R128HUCEC1
p.R10IUCEC1
p.R128CSKCM1
p.S44CSTAD1
p.T68NLGG1
p.D147NREAD1
p.M121LSKCM1
p.R173TBLCA1
p.K21QPRAD1
p.D147YLUAD1


Top
TissGeneCNV for EIF4E

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for EIF4E

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP
Chimerdb3.0ChiTaRsNABF879888ABCA1-EIF4Echr9:107589344chr4:99809803
Chimerdb3.0ChiTaRsNADA724990EIF4E-UBXN7chr4:99850284chr3:196118683


Top
TissGeneNet for EIF4E

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
EIF4E, SMYD2, ELAVL1, UBC, HNRNPK, PRDM4, SUMO1, RPS6KB1, G3BP1, STUB1, PAK2, PML, EIF3B, RPS6KA5, INTS6, DDX3X, EIF4G1, EIF4EBP1, EIF4G2, MKNK2, HSPB2 (tumor)EIF4E, GEMIN5, HNRNPK, PRDM4, RPS6KB1, G3BP1, LRPPRC, STUB1, PAK2, PML, EIF3F, EIF4G3, RPS6, INTS6, DDX3X, CYFIP1, MTOR, MAPKAPK5, EIF4G2, MKNK1, HSPB2 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
EIF4E, SMYD2, PRDM4, SUMO1, RPS6KB1, G3BP1, EIF4A1, EIF4ENIF1, PML, EIF4G3, RPS6, EIF4G1, CYFIP1, MTOR, EIF4EBP1, MAPKAPK5, EIF4B, EIF4G2, MKNK2, ANKHD1, EIF4EBP2 (tumor)EIF4E, TRAF6, ELAVL1, PRKCA, HNRNPK, HNRNPD, SUMO1, MYC, G3BP1, HDAC4, LRPPRC, EIF4A1, RPS6KA5, EIF4G3, RPS6, MTOR, EIF4EBP1, MAPKAPK5, EIF4G2, ANKHD1, HSPB2 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
EIF4E, GEMIN5, SMYD2, PRKCA, HNRNPK, PRDM4, MYC, RPS6KB1, G3BP1, EMX2, EIF4A1, RPS6, INTS6, DDX3X, EIF4G1, CYFIP1, EIF4B, EIF4A2, EIF4G2, EIF4EBP3, EIF4EBP2 (tumor)EIF4E, PRKCG, PRKCA, HNRNPK, HNRNPD, PRDM4, MYC, RPS6KB1, EMX2, EIF4A1, EIF4ENIF1, EIF4G3, INTS6, DDX3X, DCC, PRKCB, EIF4A2, EIF4G2, ANKHD1, EIF4EBP3, CD83 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
EIF4E, GEMIN5, SMYD2, ELAVL1, PRKCA, HNRNPK, HNRNPD, SUMO1, HDAC4, STUB1, PML, EIF3B, RPS6, EIF4G1, CYFIP1, MTOR, MAPKAPK5, EIF4A2, EIF4G2, ANKHD1, HSPB2 (tumor)EIF4E, GEMIN5, TRAF6, SMYD2, UBC, PRKCG, HNRNPD, PRDM4, HDAC4, EIF4A1, PML, INTS6, DDX3X, MTOR, EIF4EBP1, MAPKAPK5, EIF4B, EIF4G2, MKNK1, HSPB2, EIF4EBP2 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
EIF4E, HNRNPK, HNRNPD, SUMO1, G3BP1, HDAC4, PAK2, EIF3B, RPS6KA5, VCL, EIF4G3, INTS6, EIF4G1, DCC, MAPKAPK5, EIF4A2, EIF4G2, MKNK2, ANKHD1, EIF4EBP3, EIF4EBP2 (tumor)EIF4E, TRAF6, UBC, HNRNPK, PRDM4, SUMO1, G3BP1, HDAC4, LRPPRC, PAK2, PML, EIF3B, INTS6, DDX3X, EIF4EBP1, MAPKAPK5, EIF4A2, EIF4G2, MKNK1, HSPB2, EIF4EBP3 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
EIF4E, GEMIN5, TRAF6, PRKCA, HNRNPK, HNRNPD, SUMO1, G3BP1, HDAC4, EIF4A1, EIF4ENIF1, PML, RPS6KA5, RPS6, INTS6, EIF4G1, CYFIP1, DCC, PRKCB, MAPKAPK5, EIF4A2 (tumor)EIF4E, GEMIN5, TRAF6, HNRNPK, PRDM4, SUMO1, G3BP1, LRPPRC, PAK2, PML, EIF3B, RPS6KA5, VCL, EIF4G3, INTS6, DDX3X, CYFIP1, EIF4B, EIF4A2, EIF4G2, HSPB2 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
EIF4E, ELAVL1, PRKCG, PRKCA, HNRNPK, HNRNPD, SUMO1, MYC, RPS6KB1, G3BP1, HDAC4, EIF4A1, PAK2, VCL, INTS6, DDX3X, MTOR, EIF4G2, MKNK2, EIF4EBP2, CD83 (tumor)EIF4E, GEMIN5, ELAVL1, HNRNPK, HNRNPD, PRDM4, RPS6KB1, G3BP1, HDAC4, STUB1, EIF3B, RPS6KA5, VCL, EIF4G3, INTS6, DDX3X, CYFIP1, MTOR, PRKCB, EIF4G2, EIF4EBP3 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
EIF4E, GEMIN5, SMYD2, PRKCA, HNRNPK, PRDM4, SUMO1, G3BP1, HDAC4, EIF4A1, EIF4ENIF1, PML, EIF4G3, RPS6, EIF4G1, MTOR, DCC, EIF4G2, MKNK2, ANKHD1, EIF4EBP2 (tumor)EIF4E, HNRNPK, SUMO1, MYC, G3BP1, HDAC4, LRPPRC, EIF4A1, PAK2, EIF4ENIF1, RPS6, INTS6, MTOR, EIF4EBP1, DCC, PRKCB, MAPKAPK5, EIF4G2, MKNK2, MKNK1, ANKHD1 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
EIF4E, GEMIN5, TRAF6, PRKCA, HNRNPK, PRDM4, SUMO1, RPS6KB1, G3BP1, HDAC4, EIF4A1, EIF4ENIF1, EIF4G3, RPS6, INTS6, EIF4G1, CYFIP1, MTOR, EIF4B, EIF4G2, MKNK2 (tumor)EIF4E, PRKCG, PRKCA, HNRNPD, PRDM4, SUMO1, RPS6KB1, G3BP1, HDAC4, LRPPRC, EIF4A1, PML, RPS6KA5, VCL, EIF4G3, RPS6, EIF4G1, MTOR, EIF4EBP1, MAPKAPK5, ANKHD1 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
EIF4E, SMYD2, HNRNPK, PRDM4, SUMO1, RPS6KB1, G3BP1, HDAC4, EMX2, EIF4A1, PML, EIF4G3, RPS6, EIF4G1, DCC, MAPKAPK5, EIF4A2, EIF4G2, MKNK2, ANKHD1, EIF4EBP2 (tumor)EIF4E, ELAVL1, HNRNPK, SUMO1, RPS6KB1, G3BP1, LRPPRC, STUB1, PAK2, PML, RPS6KA5, EIF4G3, INTS6, DDX3X, CYFIP1, PRKCB, MAPKAPK5, EIF4G2, MKNK1, HSPB2, EIF4EBP3 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
EIF4E, SMYD2, PRKCG, PRKCA, HNRNPK, SUMO1, EIF4A1, PML, EIF3F, EIF3B, RPS6, DDX3X, EIF4G1, MTOR, EIF4EBP1, DCC, PRKCB, EIF4A2, EIF4G2, EIF4EBP3, CD83 (tumor)EIF4E, SMYD2, ELAVL1, PRKCA, HNRNPK, HNRNPD, SUMO1, RPS6KB1, G3BP1, HDAC4, LRPPRC, EIF4A1, VCL, RPS6, EIF4EBP1, PRKCB, MAPKAPK5, EIF4A2, EIF4G2, HSPB2, EIF4EBP2 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
EIF4E, SMYD2, PRKCA, HNRNPK, SUMO1, RPS6KB1, HDAC4, PML, EIF3F, VCL, EIF4G3, INTS6, EIF4EBP1, DCC, PRKCB, EIF4B, EIF4G2, MKNK2, MKNK1, HSPB2, CD83 (tumor)EIF4E, TRAF6, ELAVL1, PRKCG, PRKCA, HNRNPK, SUMO1, RPS6KB1, HDAC4, LRPPRC, PML, EIF3F, EIF3B, RPS6KA5, EIF4G3, INTS6, DDX3X, EIF4G2, MKNK1, HSPB2, CD83 (normal)
bullet pointbullet point


Top
TissGeneProg for EIF4E

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)
* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for EIF4E
TissGeneDrug for EIF4E

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for EIF4E

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0596263Carcinogenesis32BeFree
umls:C0006142Malignant neoplasm of breast23BeFree
umls:C0678222Breast Carcinoma23BeFree
umls:C0023467Leukemia, Myelocytic, Acute21BeFree
umls:C0027627Neoplasm Metastasis13BeFree
umls:C0376358Malignant neoplasm of prostate12BeFree
umls:C0598766Leukemogenesis12BeFree
umls:C0600139Prostate carcinoma12BeFree
umls:C0023418leukemia11BeFree
umls:C0035934Rubinstein-Taybi Syndrome11BeFree
umls:C0178874Tumor Progression10BeFree
umls:C0007131Non-Small Cell Lung Carcinoma7BeFree
umls:C0007137Squamous cell carcinoma7BeFree,LHGDN
umls:C0032339Rothmund-Thomson syndrome7BeFree
umls:C0035372Rett Syndrome7BeFree
umls:C0242379Malignant neoplasm of lung6BeFree
umls:C0280100Solid tumour6BeFree
umls:C0684249Carcinoma of lung6BeFree
umls:C1458155Mammary Neoplasms6BeFree,LHGDN
umls:C0025202melanoma5BeFree
umls:C1168401Squamous cell carcinoma of the head and neck5BeFree
umls:C0001418Adenocarcinoma4BeFree,LHGDN
umls:C0007102Malignant tumor of colon4BeFree
umls:C0026764Multiple Myeloma4BeFree
umls:C0085669Acute leukemia4BeFree
umls:C0699790Colon Carcinoma4BeFree
umls:C1336735Treatment related acute myeloid leukaemia4BeFree
umls:C0009402Colorectal Carcinoma3BeFree
umls:C0024299Lymphoma3BeFree
umls:C0042769Virus Diseases3BeFree
umls:C0079744Diffuse Large B-Cell Lymphoma3BeFree
umls:C0152013Adenocarcinoma of lung (disorder)3BeFree
umls:C0152018Esophageal carcinoma3BeFree
umls:C0278996Cancer of Head and Neck3BeFree
umls:C0279626Squamous cell carcinoma of esophagus3BeFree
umls:C0699791Stomach Carcinoma3BeFree
umls:C0008073Developmental Disabilities2BeFree
umls:C0014859Esophageal Neoplasms2BeFree
umls:C0016667Fragile X Syndrome2BeFree
umls:C0017636Glioblastoma2BeFree
umls:C0017638Glioma2BeFree
umls:C0018817Atrial Septal Defects2BeFree
umls:C0019348Herpes Simplex Infections2BeFree
umls:C0021400Influenza2BeFree
umls:C0023479Acute myelomonocytic leukemia2BeFree
umls:C0023524Leukoencephalopathy, Progressive Multifocal2BeFree
umls:C0024121Lung Neoplasms2BeFree
umls:C0024305Lymphoma, Non-Hodgkin2BeFree
umls:C0024623Malignant neoplasm of stomach2BeFree
umls:C0025362Mental Retardation2BeFree
umls:C0025500Mesothelioma2BeFree
umls:C0029925Ovarian Carcinoma2BeFree
umls:C0233794Memory impairment2BeFree
umls:C0235974Pancreatic carcinoma2BeFree
umls:C0243026Sepsis2BeFree,RGD
umls:C0334634Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse2BeFree,CTD_human
umls:C0338106Adenocarcinoma of colon2BeFree
umls:C0346647Malignant neoplasm of pancreas2BeFree
umls:C0376545Hematologic Neoplasms2BeFree
umls:C0476089Endometrial Carcinoma2BeFree
umls:C0546837Malignant neoplasm of esophagus2BeFree
umls:C0751688Malignant Squamous Cell Neoplasm2BeFree
umls:C1140680Malignant neoplasm of ovary2BeFree
umls:C1176475Ductal Carcinoma2BeFree
umls:C1519670Tumor Angiogenesis2BeFree
umls:C2239176Liver carcinoma2BeFree
umls:C2745900Promyelocytic leukemia2BeFree
umls:C2931822Nasopharyngeal carcinoma2BeFree
umls:C3539878Triple Negative Breast Neoplasms2BeFree
umls:C0001430Adenoma1BeFree
umls:C0001486Adenovirus Infections1BeFree
umls:C0002395Alzheimer's Disease1BeFree
umls:C0004352Autistic Disorder1BeFree,MGD
umls:C0004364Autoimmune Diseases1BeFree
umls:C0006840Candidiasis1BeFree
umls:C0007103Malignant neoplasm of endometrium1BeFree
umls:C0007107Malignant neoplasm of larynx1BeFree
umls:C0007113Rectal Carcinoma1BeFree
umls:C0007120Bronchioloalveolar Adenocarcinoma1BeFree
umls:C0007124Noninfiltrating Intraductal Carcinoma1BeFree
umls:C0007133Carcinoma, Papillary1LHGDN
umls:C0007138Carcinoma, Transitional Cell1BeFree
umls:C0007847Malignant tumor of cervix1BeFree
umls:C0009375Colonic Neoplasms1LHGDN
umls:C0011269Dementia, Vascular1RGD
umls:C0018671Head and Neck Neoplasms1LHGDN
umls:C0018939Hematological Disease1BeFree
umls:C0019196Hepatitis C1BeFree
umls:C0019829Hodgkin Disease1LHGDN
umls:C0023480Leukemia, Myelomonocytic, Chronic1BeFree
umls:C0023492Leukemia, T-Cell1BeFree
umls:C0023493Adult T-Cell Lymphoma/Leukemia1BeFree
umls:C0023827liposarcoma1BeFree
umls:C0024117Chronic Obstructive Airway Disease1BeFree
umls:C0024141Lupus Erythematosus, Systemic1BeFree
umls:C0027962Melanocytic nevus1BeFree
umls:C0032584polyps1BeFree
umls:C0033860Psoriasis1BeFree
umls:C0036690Septicemia1BeFree
umls:C0040136Thyroid Neoplasm1LHGDN
umls:C0040336Tobacco Use Disorder1GAD
umls:C0041408Turner Syndrome1BeFree
umls:C0085215Ovarian Failure, Premature1BeFree
umls:C0086692Benign Neoplasm1BeFree
umls:C0087012Ataxia, Spinocerebellar1BeFree
umls:C0149925Small cell carcinoma of lung1BeFree
umls:C0151744Myocardial Ischemia1RGD
umls:C0206650Fibroadenoma1BeFree
umls:C0206698Cholangiocarcinoma1BeFree
umls:C0238463Papillary thyroid carcinoma1BeFree
umls:C0242225Color blindness1BeFree
umls:C0242343Panhypopituitarism1BeFree
umls:C0266999Vesicular Stomatitis1LHGDN
umls:C0278488Carcinoma breast stage IV1BeFree
umls:C0279000Liver and Intrahepatic Biliary Tract Carcinoma1BeFree
umls:C0279628Adenocarcinoma Of Esophagus1BeFree
umls:C0302592Cervix carcinoma1BeFree
umls:C0333463Senile Plaques1BeFree
umls:C0345904Malignant neoplasm of liver1BeFree
umls:C0752120Spinocerebellar Ataxia Type 11BeFree
umls:C0854985Adenocarcinoma of lung, stage I1BeFree
umls:C0919267ovarian neoplasm1LHGDN
umls:C0949059Polyp of large intestine1BeFree
umls:C1153706Endometrial adenocarcinoma1BeFree
umls:C1261473Sarcoma1BeFree
umls:C1275808Congenital central hypoventilation1BeFree
umls:C1292780Therapy-related myelodysplastic syndrome1BeFree
umls:C1332225Aggressive Non-Hodgkin Lymphoma1BeFree
umls:C1335302Pancreatic Ductal Adenocarcinoma1BeFree
umls:C1510586Autism Spectrum Disorders1BeFree
umls:C1511291Breast Cancer Model1BeFree
umls:C1516170Cancer Cell Growth1BeFree
umls:C1527249Colorectal Cancer1BeFree
umls:C1535926Neurodevelopmental Disorders1BeFree
umls:C1704272Benign Prostatic Hyperplasia1BeFree
umls:C1883486Uterine Corpus Cancer1BeFree
umls:C2145472Urothelial Carcinoma1BeFree
umls:C2825306Treatment related leukaemia1BeFree
umls:C3714514Infection1LHGDN
umls:C3714524Fibromyxosarcoma1BeFree
umls:C3554495AUTISM, SUSCEPTIBILITY TO, 190CLINVAR